134 related articles for article (PubMed ID: 26892607)
1. Overexpression of proteasomal activator PA28α serves as a prognostic factor in oral squamous cell carcinoma.
Feng X; Jiang Y; Xie L; Jiang L; Li J; Sun C; Xu H; Wang R; Zhou M; Zhou Y; Dan H; Wang Z; Ji N; Deng P; Liao G; Geng N; Wang Y; Zhang D; Lin Y; Ye L; Liang X; Li L; Luo G; Feng M; Fang J; Zeng X; Wang Z; Chen Q
J Exp Clin Cancer Res; 2016 Feb; 35():35. PubMed ID: 26892607
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
3. Association of Notch4 with metastasis in human oral squamous cell carcinoma.
Mk H; Prince S; Mohan AM; Krishnan KV; Devi A
Life Sci; 2016 Jul; 156():38-46. PubMed ID: 27197026
[TBL] [Abstract][Full Text] [Related]
4. Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma.
Cheng CW; Hsiao JR; Fan CC; Lo YK; Tzen CY; Wu LW; Fang WY; Cheng AJ; Chen CH; Chang IS; Jiang SS; Chang JY; Lee AY
Mol Carcinog; 2016 May; 55(5):499-513. PubMed ID: 25728212
[TBL] [Abstract][Full Text] [Related]
5. Decreased microRNA-143 expression and its tumor suppressive function in human oral squamous cell carcinoma.
Ni ZY; Lin FO; Liu DF; Xiao J
Genet Mol Res; 2015 Jun; 14(2):6943-52. PubMed ID: 26125902
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of kallikrein-related peptidase-4 in oral cancer.
Papagerakis P; Pannone G; Zheng LI; Athanassiou-Papaefthymiou M; Yamakoshi Y; McGuff HS; Shkeir O; Ghirtis K; Papagerakis S
Anticancer Res; 2015 Apr; 35(4):1861-6. PubMed ID: 25862839
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
8. Role of EZH2 in oral squamous cell carcinoma carcinogenesis.
Zhao L; Yu Y; Wu J; Bai J; Zhao Y; Li C; Sun W; Wang X
Gene; 2014 Mar; 537(2):197-202. PubMed ID: 24424512
[TBL] [Abstract][Full Text] [Related]
9. Decreased brain-expressed X-linked 4 (BEX4) expression promotes growth of oral squamous cell carcinoma.
Gao W; Li JZ; Chen SQ; Chu CY; Chan JY; Wong TS
J Exp Clin Cancer Res; 2016 Jun; 35(1):92. PubMed ID: 27297407
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer.
Fang KH; Kao HK; Chi LM; Liang Y; Liu SC; Hseuh C; Liao CT; Yen TC; Yu JS; Chang KP
Laryngoscope; 2014 Sep; 124(9):E354-60. PubMed ID: 24706327
[TBL] [Abstract][Full Text] [Related]
11. UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system.
Yoshimura S; Kasamatsu A; Nakashima D; Iyoda M; Kasama H; Saito T; Takahara T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2017 Apr; 485(4):820-825. PubMed ID: 28257844
[TBL] [Abstract][Full Text] [Related]
12. Nuclear STK15 expression is associated with aggressive behaviour of oral carcinoma cells in vivo and in vitro.
Kao SY; Chen YP; Tu HF; Liu CJ; Yu AH; Wu CH; Chang KW
J Pathol; 2010 Sep; 222(1):99-109. PubMed ID: 20597069
[TBL] [Abstract][Full Text] [Related]
13. Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.
Cheng AN; Jiang SS; Fan CC; Lo YK; Kuo CY; Chen CH; Liu YL; Lee CC; Chen WS; Huang TS; Wang TY; Lee AY
Cancer Lett; 2013 Sep; 337(2):218-25. PubMed ID: 23684929
[TBL] [Abstract][Full Text] [Related]
14. Increased placenta growth factor mRNA level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
Cheng SJ; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Chiang ML; Kuo MY
J Formos Med Assoc; 2013 May; 112(5):253-8. PubMed ID: 23660220
[TBL] [Abstract][Full Text] [Related]
15. Talin-1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis.
Lai MT; Hua CH; Tsai MH; Wan L; Lin YJ; Chen CM; Chiu IW; Chan C; Tsai FJ; Jinn-Chyuan Sheu J
J Pathol; 2011 Jul; 224(3):367-76. PubMed ID: 21547905
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma.
Tokuzen N; Nakashiro K; Tanaka H; Iwamoto K; Hamakawa H
Oncotarget; 2016 Jan; 7(3):2343-53. PubMed ID: 26497678
[TBL] [Abstract][Full Text] [Related]
17. Associations between proteasomal activator PA28γ and outcome of oral squamous cell carcinoma: Evidence from cohort studies and functional analyses.
Li J; Feng X; Sun C; Zeng X; Xie L; Xu H; Li T; Wang R; Xu X; Zhou X; Zhou M; Zhou Y; Dan H; Wang Z; Ji N; Deng P; Liao G; Geng N; Wang Y; Zhang D; Lin Y; Ye L; Liang X; Li L; Luo G; Jiang L; Wang Z; Chen Q
EBioMedicine; 2015 Aug; 2(8):851-8. PubMed ID: 26425691
[TBL] [Abstract][Full Text] [Related]
18. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis.
Lin SC; Liu CJ; Lin JA; Chiang WF; Hung PS; Chang KW
Oral Oncol; 2010 Mar; 46(3):204-8. PubMed ID: 20138800
[TBL] [Abstract][Full Text] [Related]
19. Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma.
Liu G; Ren X; Gao C; Zhang W
Mol Med Rep; 2015 Aug; 12(2):2225-30. PubMed ID: 25872568
[TBL] [Abstract][Full Text] [Related]
20. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]